Rising demand for minimally invasive surgeries is a major factor projected to propel growth during the forecast period.
The popularity of minimally invasive surgery is rising because it is does not require major incisions, which results in reduced scarring, less pain, shorter hospital stay, and faster recovery.
Various advanced intraoperative imaging devices such as Mobile C-arms, Computed Tomography, Intraoperative Magnetic Resonance Imaging, and ultrasound devices are widely used for minimally invasive surgeries.
Technological advancement is another major factor supporting market growth. Vendors are focusing on development of innovative and advanced products to cater to the unmet needs of surgeons.
Advanced technologies such as iMRI provide high-quality imaging and higher precision during surgery. For instance, VISIUS iMRI delivers high-quality images and real-time data during surgical procedures.
Intraoperative CT systems segment was the largest revenue-grossing segment of the overall market in 2016, due to high application of these systems in image-guided neurosurgery and orthopedic surgery
The iMRI systems segment is expected to exhibit highest growth during the forecast period owing to technological advancements and growing popularity of these systems for critical surgeries.
In the application segment, neurosurgery accounted for the largest share in 2016 and is projected to maintain its dominance throughout the forecast period.
Hospitals dominated the market in terms of revenue in 2016 because they accounted for the highest number of surgical procedures.
The North American region held the highest revenue share in 2016 and is expected to maintain its dominance during the study period due to its well-developed healthcare infrastructure.
The Asia Pacific intraoperative imaging market is expected to grow at the highest CAGR during the forecast period because of rising disposable income, developing healthcare facilities, and increasing prevalence of neurological and orthopedic disorders.
Some of the major players are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Medtronic, Ziehm Imaging GmbH, IMRIS, Deerfield Imaging, Shimadzu Corp., Brainlab AG, and NeuroLogica Corp.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government